Literature DB >> 31228750

Allopregnanolone is required for prepulse inhibition deficits induced by D1 dopamine receptor activation.

Laura J Mosher1, Roberto Cadeddu2, Sabrina Yen3, Jeffrey L Staudinger4, Francesco Traccis5, Stephen C Fowler6, Jamie L Maguire3, Marco Bortolato7.   

Abstract

INTRODUCTION: The extraction of salient information from the environment is modulated by the activation of dopamine receptors. Using rodent models, we previously reported that gating deficits caused by dopamine receptor activation - as measured by the prepulse inhibition (PPI) of startle - are effectively opposed by inhibitors of the steroidogenic enzyme 5α-reductase (5αR). The specific 5αR isoenzyme and steroids implicated in these effects, however, remain unknown.
METHODS: The effects of the selective D1 dopamine receptor agonist SKF-82958 (SKF, 0.3 mg/kg, IP) and D2 receptor agonist quinpirole (QUIN, 0.5 mg/kg, IP) were tested in the startle reflex and PPI of knockout (KO) mice for either 5αR type 1 (5αR1) or type 2 (5αR2). Furthermore, we established whether these effects may be modified by the 5α-reduced steroids dihydroprogesterone (DHP), allopregnanolone (AP), dihydrotestosterone (DHT), 5α-androstane-3α,17β-diol (3α-diol), or androsterone. To test the mechanisms whereby 5αR products may alter the PPI-disrupting properties of D1 agonists, we studied the involvement of GABA-A and PXR, two receptors targeted by neuroactive steroids. Specifically, we tested the effects of SKF in combination with the GABA-A antagonist bicuculline, as well as in KO mice for the GABA-A δ subunit and PXR.
RESULTS: 5αR1, but not 5αR2, knockout (KO) mice were insensitive to the PPI-disrupting effects of SKF. This sensitivity was reinstated by AP (3 mg/kg, IP), but not other 5α-reduced steroids. The PPI deficits induced by SKF were not modified by bicuculline, δ-subunit KO mice and PXR KO mice.
CONCLUSIONS: These results collectively suggest that 5αR1 enables the negative effects of D1 dopamine receptor activation on information processing via production of AP. The contribution of AP to the PPI-disrupting mechanisms of D1 receptor agonists, however, do not appear to be mediated by either GABA-A or PXR receptors.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  5α-reductase; Allopregnanolone; Behavioral studies; D(1)receptors; Dopamine; Sensorimotor gating

Mesh:

Substances:

Year:  2019        PMID: 31228750      PMCID: PMC6773911          DOI: 10.1016/j.psyneuen.2019.06.009

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  51 in total

1.  The D1CT-7 mouse model of Tourette syndrome displays sensorimotor gating deficits in response to spatial confinement.

Authors:  Sean C Godar; Laura J Mosher; Hunter J Strathman; Andrea M Gochi; Cori M Jones; Stephen C Fowler; Marco Bortolato
Journal:  Br J Pharmacol       Date:  2015-08-10       Impact factor: 8.739

2.  Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor.

Authors:  M D Majewska; N L Harrison; R D Schwartz; J L Barker; S M Paul
Journal:  Science       Date:  1986-05-23       Impact factor: 47.728

Review 3.  Steroid 5α-reductase as a novel therapeutic target for schizophrenia and other neuropsychiatric disorders.

Authors:  Silvia Paba; Roberto Frau; Sean C Godar; Paola Devoto; Francesco Marrosu; Marco Bortolato
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

4.  Inhibition of 5α-reductase in the nucleus accumbens counters sensorimotor gating deficits induced by dopaminergic activation.

Authors:  Paola Devoto; Roberto Frau; Valentina Bini; Giuliano Pillolla; Pierluigi Saba; Giovanna Flore; Marta Corona; Francesco Marrosu; Marco Bortolato
Journal:  Psychoneuroendocrinology       Date:  2011-10-24       Impact factor: 4.905

5.  Activation of D1, but not D2 receptors potentiates dizocilpine-mediated disruption of prepulse inhibition of the startle.

Authors:  Marco Bortolato; Gian Nicola Aru; Mauro Fà; Roberto Frau; Marco Orrù; Paola Salis; Alberto Casti; Grant Christopher Luckey; Giampaolo Mereu; Gian Luigi Gessa
Journal:  Neuropsychopharmacology       Date:  2005-03       Impact factor: 7.853

6.  Tissue distribution and kinetic characteristics of rat steroid 5 alpha-reductase isozymes. Evidence for distinct physiological functions.

Authors:  K Normington; D W Russell
Journal:  J Biol Chem       Date:  1992-09-25       Impact factor: 5.157

7.  Pharmacological characterization of a novel cell line expressing human alpha(4)beta(3)delta GABA(A) receptors.

Authors:  N Brown; J Kerby; T P Bonnert; P J Whiting; K A Wafford
Journal:  Br J Pharmacol       Date:  2002-08       Impact factor: 8.739

8.  Seroquel (ICI 204,636) restores prepulse inhibition of acoustic startle in apomorphine-treated rats: Similarities to clozapine.

Authors:  N R Swerdlow; D Zisook; N Taaid
Journal:  Psychopharmacology (Berl)       Date:  1994-05       Impact factor: 4.530

9.  The neurosteroidogenic enzyme 5α-reductase modulates the role of D1 dopamine receptors in rat sensorimotor gating.

Authors:  Roberto Frau; Laura J Mosher; Valentina Bini; Giuliano Pillolla; Romina Pes; Pierluigi Saba; Silvia Fanni; Paola Devoto; Marco Bortolato
Journal:  Psychoneuroendocrinology       Date:  2015-09-24       Impact factor: 4.905

Review 10.  Novel receptor targets for production and action of allopregnanolone in the central nervous system: a focus on pregnane xenobiotic receptor.

Authors:  Cheryl A Frye; Carolyn J Koonce; Alicia A Walf
Journal:  Front Cell Neurosci       Date:  2014-04-09       Impact factor: 5.505

View more
  3 in total

Review 1.  Neurobehavioural complications of sleep deprivation: Shedding light on the emerging role of neuroactive steroids.

Authors:  Roberto Frau; Francesco Traccis; Marco Bortolato
Journal:  J Neuroendocrinol       Date:  2019-09-30       Impact factor: 3.627

Review 2.  Allopregnanolone: The missing link to explain the effects of stress on tic exacerbation?

Authors:  Marco Bortolato; Barbara J Coffey; Vilma Gabbay; Simona Scheggi
Journal:  J Neuroendocrinol       Date:  2021-08-22       Impact factor: 3.870

Review 3.  Allopregnanolone: An overview on its synthesis and effects.

Authors:  Silvia Diviccaro; Lucia Cioffi; Eva Falvo; Silvia Giatti; Roberto Cosimo Melcangi
Journal:  J Neuroendocrinol       Date:  2021-06-29       Impact factor: 3.870

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.